A New Nano-Platform for Drug Release via Nanotubular Aluminum Oxide

Kunbae Noh, Karla S. Brammer, Chulmin Choi, Seung Hyun Kim, Christine J. Frandsen, Sungho Jin

.

DOI: 10.4236/jbnb.2011.23028                

Abstract

Nanotubular materials have many favorable properties for drug delivery. We present here a pioneering study of controlled release of a model drug, amoxicillin, from the internal nanopore structure of self-ordered, periodically spaced-apart aluminum oxide with an innovative, nanotubular geometry. This aluminum oxide nanotube geometry has not yet been revealed for biological applications, thus we have selected this oxide nanotube structure and demonstrated its ability as a drug carrier. Controlled, sustained release was achieved for over 5 weeks. The release kinetics from the nanotube layer was thoroughly characterized and it was determined that the amount of drug released was proportional to the square root of time. This type of controlled release and longevity from the nanotube layer has potential for therapeutic surface coatings on medical implants. Furthermore, this type of geometry has many features that are advantageous and biologically relevant for enhancing tissue biointegration.

Keywords

AAO, nanotube, antibiotics, drug release, implant surface

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Masuda, H. and K. Fukuda, Ordered Metal Nanohole Arrays Made by a 2-Step Replication of Honeycomb Structures of Anodic Alumina. Science, 1995. 268(5216): p. 1466-1468.
[2]	Gultepe, E., et al., Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices. Adv Drug Deliv Rev, 2010. 62(3): p. 305-315.
[3]	Darder, M., et al., Encapsulation of enzymes in alumina membranes of controlled pore size. Thin Solid Films, 2006. 495(1-2): p. 321-326.
[4]	Briggs, E.P., et al., Formation of highly adherent nano-porous alumina on Ti-based substrates: a novel bone implant coating. Journal of Materials Science-Materials in Medicine, 2004. 15(9): p. 1021-1029.
[5]	Walpole, A.R., et al., Nano-porous alumina coatings for improved bone implant interfaces. Materialwissenschaft Und Werkstofftechnik, 2003. 34(12): p. 1064-1068.
[6]	Huang, K.T., Z. Huang, and D.B. Kim-Shapiro, Nitric oxide red blood cell membrane permeability at high and low oxygen tension. Nitric Oxide-Biology and Chemistry, 2007. 16(2): p. 209-216.
[7]	Kang, H.J., et al., Controlled drug release using nanoporous anodic aluminum oxide on stent. Thin Solid Films, 2007. 515(12): p. 5184-5187.
[8]	Wieneke, H., et al., Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. Catheterization and Cardiovascular Interventions, 2003. 60(3): p. 399-407.
[9]	Gong, D.W., et al., Controlled molecular release using nanoporous alumina capsules. Biomedical Microdevices, 2003. 5(1): p. 75-80.
[10]	Gultepe, E., et al., Sustained drug release from non-eroding nanoporous templates. Small, 2010. 6(2): p. 213-6.
[11]	Losic, D. and S. Simovic, Self-ordered nanopore and nanotube platforms for drug delivery applications. Expert Opin Drug Deliv, 2009. 6(12): p. 1363-81.
[12]	Yao, C. and T.J. Webster, Prolonged Antibiotic Delivery From Anodized Nanotubular Titanium Using a Co-precipitation Drug Loading Method. Journal of Biomedical Materials Research Part B-Applied Biomaterials, 2009. 91B(2): p. 587-595.
[13]	Popat, K.C., et al., Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials, 2007. 28(21): p. 3188-97.
[14]	Popat, K.C., et al., Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials, 2007. 28(32): p. 4880-8.
[15]	Peng, L., et al., Long-term small molecule and protein elution from TiO2 nanotubes. Nano Lett, 2009. 9(5): p. 1932-6.
[16]	Oh, S., et al., Significantly accelerated osteoblast cell growth on aligned TiO2 nanotubes. Journal of Biomedical Materials Research Part A, 2006. 78(1): p. 97-103.
[17]	Oh, S., et al., Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci U S A, 2009. 106(7): p. 2130-5.
[18]	Brammer, K.S., et al., Improved bone-forming functionality on diameter-controlled TiO(2) nanotube surface. Acta Biomater, 2009. 5(8): p. 3215-23.
[19]	Bjursten, L.M., Ramusson L, Oh S, et al., Titanium Dioxide Nanotubes Enhance Bone Bonding In Vivo. J Biomed Mater Res A, 2009.
[20]	NG, C.L., S; Chan, C, Research Highlights: Highlights from the latest articles in nanomedicine. Nanomedicine, 2009. 4(4): p. 381-383.
[21]	Lee, W., et al., Fast fabrication of long-range ordered porous alumina membranes by hard anodization. Nature Materials, 2006. 5(9): p. 741-747.
[22]	Lee, W., et al., Structural engineering of nanoporous anodic aluminium oxide by pulse anodization of aluminium. Nature Nanotechnology, 2008. 3(4): p. 234-239.
[23]	Schwirn, K., et al., Self-ordered anodic aluminum oxide formed by H2SO4 hard anodization. ACS Nano, 2008. 2(2): p. 302-310.
[24]	Zhao, S.Y., et al., Novel structure of AAO film fabricated by constant current anodization. Advanced Materials, 2007. 19(19): p. 3004-+.
[25]	Li, A.P., et al., Hexagonal pore arrays with a 50-420 nm interpore distance formed by self-organization in anodic alumina. Journal of Applied Physics, 1998. 84(11): p. 6023-6026.
[26]	Vallet-Regi, M., et al., Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin. Solid State Ionics, 2004. 172(1-4): p. 435-439.
[27]	Geisler, S., Orally administered amoxicillin decreases the risk of implant failures. J Am Dent Assoc, 2009. 140(10): p. 1294-6.
[28]	Esposito, M., et al., Interventions for replacing missing teeth: antibiotics at dental implant placement to prevent complications. Cochrane Database of Systematic Reviews, 2008(3): p. -.
[29]	Beardmore, A.A., et al., Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute. Journal of Bone and Joint Surgery-American Volume, 2005. 87A(1): p. 107-112.
[30]	Ostermann, P.A., D. Seligson, and S.L. Henry, Local antibiotic therapy for severe open fractures. A review of 1085 consecutive cases. J Bone Joint Surg Br, 1995. 77(1): p. 93-7.
[31]	Turgut, H., et al., Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection. Bmc Infectious Diseases, 2005. 5: p. -.
[32]	Das, K., et al., Surface coatings for improvement of bone cell materials and antimicrobial activities of Ti implants. J Biomed Mater Res B Appl Biomater, 2008. 87(2): p. 455-60.
[33]	Oh, S., et al., Significantly accelerated osteoblast cell growth on aligned TiO2 nanotubes. J Biomed Mater Res A, 2006. 78(1): p. 97-103.
[34]	Mark Saltzman, W. and S.P. Baldwin, Materials for protein delivery in tissue engineering. Adv Drug Deliv Rev, 1998. 33(1-2): p. 71-86.
[35]	Rosenholm, J.M. and M. Linden, Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications. J Control Release, 2008. 128(2): p. 157-64.
[36]	Jiang, G., et al., Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. J Control Release, 2002. 79(1-3): p. 137-45.
[37]	Martin, F., et al., Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics. J Control Release, 2005. 102(1): p. 123-33.
[38]	Bayomi, M.A., Geometric Approach for Zero-Order Release of Drugs Dispersed in an Inert Matrix. Pharmaceutical Research, 1994. 11(6): p. 914-916.
[39]	Higuchi, T., Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci, 1961. 50: p. 874-5.
[40]	Higuchi, T., Mechanism of Sustained-Action Medication. Theoretical Analysis of Rate of Release of Solid Drugs Dispersed in Solid Matrices. J Pharm Sci, 1963. 52: p. 1145-9.
[41]	Roy, I., et al., Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc, 2003. 125(26): p. 7860-5.
[42]	Popat, K.C., et al., Titania nanotubes: a novel platform for drug-eluting coatings for medical implants? Small, 2007. 3(11): p. 1878-81.